BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32873881)

  • 1. Quantifying drug tissue biodistribution by integrating high content screening with deep-learning analysis.
    Li Z; Xiao Y; Peng J; Locke D; Holmes D; Li L; Hamilton S; Cook E; Myer L; Vanderwall D; Cloutier N; Siddiqui AM; Whitehead P; Bishop R; Zhao L; Cvijic ME
    Sci Rep; 2020 Sep; 10(1):14408. PubMed ID: 32873881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Learning-Based HCS Image Analysis for the Enterprise.
    Steigele S; Siegismund D; Fassler M; Kustec M; Kappler B; Hasaka T; Yee A; Brodte A; Heyse S
    SLAS Discov; 2020 Aug; 25(7):812-821. PubMed ID: 32432952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCS Methodology for Helping in Lab Scale Image-Based Assays.
    Soriano J; Mata G; Megias D
    Methods Mol Biol; 2019; 2040():331-356. PubMed ID: 31432486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CellProfiler and KNIME: Open-Source Tools for High-Content Screening.
    Stöter M; Janosch A; Barsacchi R; Bickle M
    Methods Mol Biol; 2019; 1953():43-60. PubMed ID: 30912015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High content screening in chemical biology: overview and main challenges].
    Brodin P; DelNery E; Soleilhac E
    Med Sci (Paris); 2015 Feb; 31(2):187-96. PubMed ID: 25744266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intelligent Image-Activated Cell Sorting.
    Nitta N; Sugimura T; Isozaki A; Mikami H; Hiraki K; Sakuma S; Iino T; Arai F; Endo T; Fujiwaki Y; Fukuzawa H; Hase M; Hayakawa T; Hiramatsu K; Hoshino Y; Inaba M; Ito T; Karakawa H; Kasai Y; Koizumi K; Lee S; Lei C; Li M; Maeno T; Matsusaka S; Murakami D; Nakagawa A; Oguchi Y; Oikawa M; Ota T; Shiba K; Shintaku H; Shirasaki Y; Suga K; Suzuki Y; Suzuki N; Tanaka Y; Tezuka H; Toyokawa C; Yalikun Y; Yamada M; Yamagishi M; Yamano T; Yasumoto A; Yatomi Y; Yazawa M; Di Carlo D; Hosokawa Y; Uemura S; Ozeki Y; Goda K
    Cell; 2018 Sep; 175(1):266-276.e13. PubMed ID: 30166209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting the whole picture: High content screening using three-dimensional cellular model systems and whole animal assays.
    Kriston-Vizi J; Flotow H
    Cytometry A; 2017 Feb; 91(2):152-159. PubMed ID: 27403779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-based profiling for drug discovery: due for a machine-learning upgrade?
    Chandrasekaran SN; Ceulemans H; Boyd JD; Carpenter AE
    Nat Rev Drug Discov; 2021 Feb; 20(2):145-159. PubMed ID: 33353986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput quantification of early stages of phagocytosis.
    Yeo JC; Wall AA; Stow JL; Hamilton NA
    Biotechniques; 2013 Sep; 55(3):115-24. PubMed ID: 24003943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filling the drug discovery gap: is high-content screening the missing link?
    Dorval T; Chanrion B; Cattin ME; Stephan JP
    Curr Opin Pharmacol; 2018 Oct; 42():40-45. PubMed ID: 30032033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-content image generation for drug discovery using generative adversarial networks.
    Hussain S; Anees A; Das A; Nguyen BP; Marzuki M; Lin S; Wright G; Singhal A
    Neural Netw; 2020 Dec; 132():353-363. PubMed ID: 32977280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CellProfiler and KNIME: open source tools for high content screening.
    Stöter M; Niederlein A; Barsacchi R; Meyenhofer F; Brandl H; Bickle M
    Methods Mol Biol; 2013; 986():105-22. PubMed ID: 23436409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies and Solutions to Maintain and Retain Data from High Content Imaging, Analysis, and Screening Assays.
    Kozak K; Rinn B; Leven O; Emmenlauer M
    Methods Mol Biol; 2018; 1683():131-148. PubMed ID: 29082491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies.
    Donato MT; Gómez-Lechón MJ; Tolosa L
    Expert Opin Drug Discov; 2017 Feb; 12(2):201-211. PubMed ID: 27936962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and Opportunities in Enabling High-Throughput, Miniaturized High Content Screening.
    Nickischer D; Elkin L; Cloutier N; O'Connell J; Banks M; Weston A
    Methods Mol Biol; 2018; 1683():165-191. PubMed ID: 29082493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-based high-content screening in drug discovery.
    Lin S; Schorpp K; Rothenaigner I; Hadian K
    Drug Discov Today; 2020 Aug; 25(8):1348-1361. PubMed ID: 32561299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise review: a high-content screening approach to stem cell research and drug discovery.
    Xia X; Wong ST
    Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated image analysis for high-content screening and analysis.
    Shariff A; Kangas J; Coelho LP; Quinn S; Murphy RF
    J Biomol Screen; 2010 Aug; 15(7):726-34. PubMed ID: 20488979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrahigh-throughput single-molecule spectroscopy and spectrally resolved super-resolution microscopy.
    Zhang Z; Kenny SJ; Hauser M; Li W; Xu K
    Nat Methods; 2015 Oct; 12(10):935-8. PubMed ID: 26280329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplexed high content screening assays create a systems cell biology approach to drug discovery.
    Taylor DL; Giuliano KA
    Drug Discov Today; 2005; Suppl():13-8. PubMed ID: 23570162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.